Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 28 are a BUY (66.67%), 14 are a HOLD (33.33%).
Analyst Alex Thompson works at STIFEL with a stock forecast success ratio of 48.37% fulfilled within 104.83 days on average.
Alex Thompson’s has documented 84 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMVT, Immunovant at 21-Dec-2023.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 12/18/2023. The price target of $1 was fulfilled within 1 day with a profit of $0.06 (6.38%) receiving and performance score of 63.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
48
$0.45 (0.95%)
48
8 months 24 days ago
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
56
10 months 7 days ago
0/1 (0%)
$27.35 (95.46%)
Hold
48
$0.45 (0.95%)
68
10 months 13 days ago
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
38
10 months 13 days ago
1/2 (50%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
71
10 months 13 days ago
0/2 (0%)
$1.56 (3.36%)
Which stock is Alex Thompson is most bullish on?
Which stock is Alex Thompson is most reserved on?
What Year was the first public recommendation made by Alex Thompson?